Salt CompositionYou Searched
Uniblastin 10mg Injection
United Biotech Pvt. Ltd.
₹250
WHO GMP
Certified
Long Expiry
(>8 Months)
WHO GMP
Certified
Long Expiry
(>8 Months)
Used In
Non-Hodgkin lymphoma (NHL) / Breast cancer / Kidney cancer / Hodgkin?s disease
Customers also bought
More About Uniblastin
Benefits
In Non-Hodgkin lymphoma (NHL) Non-Hodgkin's lymphoma is a cancer of the white blood cells in our body, also called mantle-cell lymphoma. White blood cells are those cells that help us to fight infections. Uniblastin 10mg Injection helps to restrict cancer growth and also blocks the action of other chemicals that are required for cancer growth and further spread. Avoid being in crowds and wash your hands often to prevent any infections. Have plenty of fluids, unless otherwise advised by the doctor not to. In Breast cancer Uniblastin 10mg Injection helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Uniblastin 10mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you. In Kidney cancer Uniblastin 10mg Injection is used to treat kidney cancer and its associated symptoms such as blood in the urine, unexplained low back pain or weight loss, fatigue, loss of appetite, etc. It stops cancer growth and prevents multiplication of cancer cells. This restricts the advancement of cancer to other unaffected regions. You need to follow your doctor?s instructions very carefully to recover. In Hodgkin?s disease Hodgkin?s disease is a type of lymphoma, which is a blood cancer that starts in the lymphatic system. The lymphatic system helps the immune system get rid of waste and fight infections. Uniblastin 10mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Follow your doctor?s instructions carefully and let your doctor know if any of the side effects bother you.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How it works
Uniblastin 10mg Injection blocks replication of genetic material (DNA) in the cancer cells. Thus it stops the growth and multiplication of cancer cells.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Uniblastin 10mg Injection . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Uniblastin 10mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Not Safe: Uniblastin 10mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Not Safe: Uniblastin 10mg Injection may cause side effects which could affect your ability to drive.
Safe when prescribed by an expert: Uniblastin 10mg Injection is safe to use in patients with kidney disease. No dose adjustment of Uniblastin 10mg Injection is recommended. However, talk to your doctor if you have any underlying kidney disease.
Caution Advised: Uniblastin 10mg Injection should be used with caution in patients with liver disease. Dose adjustment of Uniblastin 10mg Injection may be needed. Doctor consultation is advised. Use of Uniblastin 10mg Injection may not be advised in patients with severe liver disease.
Manufacturer Address
FC/B-1 (Extn.), Mohan Co-operative Industrial Estate Mathura Road, New Delhi - 110 044
References
Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1706
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 949
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1476-77
Drugs.com. Vinblastine Pregnancy and Breastfeeding Warnings (27 Mar. 2019)
Drugs and Lactation Database (LactMed) (19 Feb. 2020)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
